Weill Cornell clinicians have begun the first clinical trial in the United States that uses a radiopharmaceutical to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy. Read more
A large grant will allow Ithaca affiliate Ankur Singh to further his study of diffuse large B-cell lymphoma and develop a lymphoma subtype-specific organoid to evaluate the pre-clinical and clinical outcomes of a new class of pathway targeting novel anti-tumor therapeutics. Read more
A study by Jeffrey Port, M.D., and colleagues suggests people suffering from lung cancer are at a higher risk of suicide than those who struggle with other forms of the disease. Read more
Researchers at Weill Cornell Medicine have discovered an innovative method to make an unlimited supply of healthy blood cells from the readily available cells that line blood vessels. Read more
Manish Shah, M.D., and Heather Yeo, M.D., comment on research that suggests that cashews and other tree nuts might be as effective as some of oncology’s most effective treatments at keeping colon cancer from recurring after surgery. Read more
Stem cells preserve their identities after cell division by using a series of protein “bookmarks” on their genes, according to new research by Effie Apostolou, Ph.D. Read more
Ethel Cesarman and colleagues have identified a compound that inhibits the growth of a rare blood cancer found in people with HIV-AIDS as well as multiple myeloma. Read more
